Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 3
2016 1
2017 1
2018 3
2019 1
2020 1
2021 4
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, Rother LM, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Stevanovic S, Tabatabai G, Steinbach JP, Bendszus M, von Deimling A, Schmitt M, Wick W. Platten M, et al. Among authors: hense j. Nature. 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24. Nature. 2021. PMID: 33762734 Free PMC article. Clinical Trial.
Electrolyte and renal disorders in patients with newly diagnosed glioblastoma.
Pierscianek D, Oppong MD, Ahmadipour Y, Rauschenbach L, Michel A, Kebir S, Dammann P, H Wrede K, Glas M, Hense J, Pöttgen C, Sure U, Jabbarli R. Pierscianek D, et al. Among authors: hense j. Future Oncol. 2021 Dec;17(34):4711-4719. doi: 10.2217/fon-2020-1312. Epub 2021 Oct 21. Future Oncol. 2021. PMID: 34672208
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.
Kraskowski O, Stratmann JA, Wiesweg M, Eberhardt W, Metzenmacher M, Schmid KW, Herold T, Schildhaus HU, Darwiche K, Aigner C, Stuschke M, Laue K, Zaun G, Kasper S, Hense J, Sebastian M, Schuler M, Pogorzelski M. Kraskowski O, et al. Among authors: hense j. J Cancer Res Clin Oncol. 2023 Sep;149(11):9243-9252. doi: 10.1007/s00432-023-04839-3. Epub 2023 May 18. J Cancer Res Clin Oncol. 2023. PMID: 37198447 Free PMC article.
Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases.
Michel A, Darkwah Oppong M, Rauschenbach L, Dinger TF, Barthel L, Pierscianek D, Wrede KH, Hense J, Pöttgen C, Junker A, Schmidt T, Iannaccone A, Kimmig R, Sure U, Jabbarli R. Michel A, et al. Among authors: hense j. Cancers (Basel). 2022 Mar 10;14(6):1437. doi: 10.3390/cancers14061437. Cancers (Basel). 2022. PMID: 35326590 Free PMC article.
Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome.
Michel A, Dinger T, Darkwah Oppong M, Rauschenbach L, Deuschl C, Ahmadipour Y, Pierscianek D, Wrede K, Hense J, Pöttgen C, Iannaccone A, Kimmig R, Sure U, Jabbarli R. Michel A, et al. Among authors: hense j. Acta Neurochir (Wien). 2022 Feb;164(2):439-449. doi: 10.1007/s00701-021-05026-4. Epub 2021 Oct 22. Acta Neurochir (Wien). 2022. PMID: 34677686 Free PMC article.
Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.
Michel A, Dinger TF, Santos AN, Pierscianek D, Darkwah Oppong M, Ahmadipour Y, Dammann P, Wrede KH, Hense J, Pöttgen C, Iannaccone A, Kimmig R, Sure U, Jabbarli R. Michel A, et al. Among authors: hense j. J Neurooncol. 2022 Aug;159(1):53-63. doi: 10.1007/s11060-022-04043-2. Epub 2022 Jun 7. J Neurooncol. 2022. PMID: 35672530 Free PMC article.
Brief S2k guidelines--Merkel cell carcinoma.
Becker JC, Assaf C, Vordermark D, Reske SN, Hense J, Dettenborn T, Seitz O, Grabbe S. Becker JC, et al. Among authors: hense j. J Dtsch Dermatol Ges. 2013 Jun;11 Suppl 3:29-36, 31-8. doi: 10.1111/ddg.12015_6. J Dtsch Dermatol Ges. 2013. PMID: 23734895 No abstract available.
HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases.
Michel A, Oppong MD, Rauschenbach L, Pierscianek D, Dinger TF, Schmidt T, Hense J, Pöttgen C, Kimmig R, Ahmadipour Y, Özkan N, Müller O, Junker A, Sure U, Jabbarli R, El Hindy N. Michel A, et al. Among authors: hense j. World Neurosurg. 2021 Aug;152:e332-e343. doi: 10.1016/j.wneu.2021.05.096. Epub 2021 May 29. World Neurosurg. 2021. PMID: 34062302
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.
Wiesweg M, Eberhardt WEE, Reis H, Ting S, Savvidou N, Skiba C, Herold T, Christoph DC, Meiler J, Worm K, Kasper S, Theegarten D, Hense J, Hager T, Darwiche K, Oezkan F, Aigner C, Welter S, Kühl H, Stuschke M, Schmid KW, Schuler M. Wiesweg M, et al. Among authors: hense j. J Thorac Oncol. 2017 Jan;12(1):54-64. doi: 10.1016/j.jtho.2016.08.137. Epub 2016 Aug 27. J Thorac Oncol. 2017. PMID: 27575422 Free article.
20 results